Resonance Health is an Australian healthcare company specialising in the development and commercialisation of medical imaging related technologies and services. Resonance has extensive experience and expertise in providing objective, reproducible, and quantitative imaging measurements and core laboratory services that are used globally in routine clinical use and in clinical trials. We provide meticulous, standardised and quality assured methodology to a comprehensive range of imaging core lab services, including liver and pancreatic fat assessments, and others services that have been used in clinical trials in various cohorts, such as paediatric NASH, adult NASH, and Type 2 diabetes, as well as longitudinal studies and assessments of relatively healthy cohorts. Our full suite of imaging services are available across a variety of organs including pancreatic fat, liver, spleen volume and other imaging technologies and can be tailored to specific protocol requirements.